nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ALB—liver cancer	0.324	1	CbGaD
Abiraterone—ABCC1—Epirubicin—liver cancer	0.175	0.423	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—liver cancer	0.0932	0.225	CbGbCtD
Abiraterone—CYP2C8—Sorafenib—liver cancer	0.0547	0.132	CbGbCtD
Abiraterone—CYP2D6—Sorafenib—liver cancer	0.0349	0.0841	CbGbCtD
Abiraterone—CYP3A4—Sorafenib—liver cancer	0.0222	0.0535	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—liver cancer	0.0212	0.051	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—liver cancer	0.0135	0.0325	CbGbCtD
Abiraterone—Potassium low—Sorafenib—liver cancer	0.00986	0.0965	CcSEcCtD
Abiraterone—ORM1—bile—liver cancer	0.00633	0.448	CbGeAlD
Abiraterone—Blood potassium decreased—Sorafenib—liver cancer	0.00543	0.0532	CcSEcCtD
Abiraterone—Lymphopenia—Sorafenib—liver cancer	0.00404	0.0395	CcSEcCtD
Abiraterone—Hypophosphataemia—Sorafenib—liver cancer	0.00355	0.0348	CcSEcCtD
Abiraterone—Myocardial ischaemia—Sorafenib—liver cancer	0.00257	0.0252	CcSEcCtD
Abiraterone—ORM1—gall bladder—liver cancer	0.00176	0.124	CbGeAlD
Abiraterone—SULT2A1—liver—liver cancer	0.00169	0.119	CbGeAlD
Abiraterone—ALB—gall bladder—liver cancer	0.00154	0.109	CbGeAlD
Abiraterone—Cardiac failure—Sorafenib—liver cancer	0.00154	0.015	CcSEcCtD
Abiraterone—Lymphopenia—Epirubicin—liver cancer	0.00149	0.0146	CcSEcCtD
Abiraterone—Hypernatraemia—Epirubicin—liver cancer	0.00145	0.0142	CcSEcCtD
Abiraterone—Lymphopenia—Doxorubicin—liver cancer	0.00138	0.0135	CcSEcCtD
Abiraterone—Hypokalaemia—Sorafenib—liver cancer	0.00136	0.0134	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00135	0.0132	CcSEcCtD
Abiraterone—Hypernatraemia—Doxorubicin—liver cancer	0.00134	0.0132	CcSEcCtD
Abiraterone—Nasopharyngitis—Sorafenib—liver cancer	0.00134	0.0131	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00132	0.013	CcSEcCtD
Abiraterone—Hypophosphataemia—Epirubicin—liver cancer	0.00131	0.0129	CcSEcCtD
Abiraterone—Hypophosphataemia—Doxorubicin—liver cancer	0.00122	0.0119	CcSEcCtD
Abiraterone—Pneumonia—Sorafenib—liver cancer	0.00116	0.0114	CcSEcCtD
Abiraterone—Infestation—Sorafenib—liver cancer	0.00116	0.0113	CcSEcCtD
Abiraterone—Infestation NOS—Sorafenib—liver cancer	0.00116	0.0113	CcSEcCtD
Abiraterone—Acute coronary syndrome—Sorafenib—liver cancer	0.00114	0.0112	CcSEcCtD
Abiraterone—Myocardial infarction—Sorafenib—liver cancer	0.00113	0.0111	CcSEcCtD
Abiraterone—Urinary tract disorder—Sorafenib—liver cancer	0.00102	0.01	CcSEcCtD
Abiraterone—Connective tissue disorder—Sorafenib—liver cancer	0.00102	0.00998	CcSEcCtD
Abiraterone—Urethral disorder—Sorafenib—liver cancer	0.00102	0.00996	CcSEcCtD
Abiraterone—Cardiac disorder—Sorafenib—liver cancer	0.000963	0.00943	CcSEcCtD
Abiraterone—Angiopathy—Sorafenib—liver cancer	0.000941	0.00922	CcSEcCtD
Abiraterone—Mediastinal disorder—Sorafenib—liver cancer	0.000935	0.00916	CcSEcCtD
Abiraterone—Arrhythmia—Sorafenib—liver cancer	0.000927	0.00908	CcSEcCtD
Abiraterone—Mental disorder—Sorafenib—liver cancer	0.000909	0.0089	CcSEcCtD
Abiraterone—Anaemia—Sorafenib—liver cancer	0.000835	0.00817	CcSEcCtD
Abiraterone—Nocturia—Epirubicin—liver cancer	0.000823	0.00806	CcSEcCtD
Abiraterone—Cough—Sorafenib—liver cancer	0.000788	0.00772	CcSEcCtD
Abiraterone—Hypertension—Sorafenib—liver cancer	0.00078	0.00764	CcSEcCtD
Abiraterone—Myalgia—Sorafenib—liver cancer	0.000769	0.00753	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000764	0.00748	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000764	0.00748	CcSEcCtD
Abiraterone—Nocturia—Doxorubicin—liver cancer	0.000762	0.00746	CcSEcCtD
Abiraterone—CYP17A1—liver—liver cancer	0.000734	0.0519	CbGeAlD
Abiraterone—Infection—Sorafenib—liver cancer	0.000732	0.00717	CcSEcCtD
Abiraterone—Fluid retention—Epirubicin—liver cancer	0.000725	0.0071	CcSEcCtD
Abiraterone—Skin disorder—Sorafenib—liver cancer	0.000716	0.00701	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000706	0.00692	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000672	0.00658	CcSEcCtD
Abiraterone—Fluid retention—Doxorubicin—liver cancer	0.000671	0.00657	CcSEcCtD
Abiraterone—Dyspnoea—Sorafenib—liver cancer	0.000657	0.00643	CcSEcCtD
Abiraterone—Dyspepsia—Sorafenib—liver cancer	0.000649	0.00635	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000637	0.00624	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Sorafenib—liver cancer	0.000636	0.00623	CcSEcCtD
Abiraterone—Fatigue—Sorafenib—liver cancer	0.000635	0.00622	CcSEcCtD
Abiraterone—Constipation—Sorafenib—liver cancer	0.00063	0.00617	CcSEcCtD
Abiraterone—Hot flush—Epirubicin—liver cancer	0.000592	0.0058	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00059	0.00577	CcSEcCtD
Abiraterone—Menopausal symptoms—Epirubicin—liver cancer	0.000587	0.00575	CcSEcCtD
Abiraterone—Body temperature increased—Sorafenib—liver cancer	0.000583	0.00571	CcSEcCtD
Abiraterone—Cardiac failure—Epirubicin—liver cancer	0.000568	0.00556	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—liver cancer	0.000548	0.00537	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—liver cancer	0.000543	0.00532	CcSEcCtD
Abiraterone—Asthenia—Sorafenib—liver cancer	0.000529	0.00518	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—liver cancer	0.000525	0.00515	CcSEcCtD
Abiraterone—ORM1—liver—liver cancer	0.000515	0.0365	CbGeAlD
Abiraterone—Hypokalaemia—Epirubicin—liver cancer	0.000504	0.00494	CcSEcCtD
Abiraterone—Diarrhoea—Sorafenib—liver cancer	0.000504	0.00494	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000499	0.00489	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—liver cancer	0.000496	0.00485	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000489	0.00479	CcSEcCtD
Abiraterone—Vomiting—Sorafenib—liver cancer	0.000469	0.00459	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—liver cancer	0.000467	0.00457	CcSEcCtD
Abiraterone—Rash—Sorafenib—liver cancer	0.000465	0.00455	CcSEcCtD
Abiraterone—Dermatitis—Sorafenib—liver cancer	0.000464	0.00455	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000462	0.00452	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—liver cancer	0.000459	0.00449	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000452	0.00443	CcSEcCtD
Abiraterone—ALB—liver—liver cancer	0.000452	0.032	CbGeAlD
Abiraterone—Upper respiratory tract infection—Epirubicin—liver cancer	0.000445	0.00436	CcSEcCtD
Abiraterone—Pollakiuria—Epirubicin—liver cancer	0.000443	0.00433	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—liver cancer	0.000432	0.00423	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—liver cancer	0.00043	0.00421	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—liver cancer	0.000427	0.00418	CcSEcCtD
Abiraterone—Infestation—Epirubicin—liver cancer	0.000427	0.00418	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—liver cancer	0.000415	0.00407	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000412	0.00403	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—liver cancer	0.000409	0.00401	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—liver cancer	0.000407	0.00399	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—liver cancer	0.0004	0.00392	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—liver cancer	0.000397	0.00389	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—liver cancer	0.000395	0.00387	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—liver cancer	0.000395	0.00387	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—liver cancer	0.000384	0.00376	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—liver cancer	0.000379	0.00371	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—liver cancer	0.000377	0.00369	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—liver cancer	0.000377	0.00369	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—liver cancer	0.000376	0.00368	CcSEcCtD
Abiraterone—ABCC1—liver—liver cancer	0.000373	0.0264	CbGeAlD
Abiraterone—Cardiac disorder—Epirubicin—liver cancer	0.000356	0.00348	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—liver cancer	0.00035	0.00343	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—liver cancer	0.000349	0.00341	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—liver cancer	0.000348	0.00341	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—liver cancer	0.000348	0.00341	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—liver cancer	0.000346	0.00338	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—liver cancer	0.000343	0.00335	CcSEcCtD
Abiraterone—Mental disorder—Epirubicin—liver cancer	0.000336	0.00329	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—liver cancer	0.000329	0.00322	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—liver cancer	0.000322	0.00315	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—liver cancer	0.00032	0.00313	CcSEcCtD
Abiraterone—CYP2C8—liver—liver cancer	0.000317	0.0225	CbGeAlD
Abiraterone—Arrhythmia—Doxorubicin—liver cancer	0.000317	0.0031	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—liver cancer	0.000311	0.00304	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—liver cancer	0.000308	0.00302	CcSEcCtD
Abiraterone—Cough—Epirubicin—liver cancer	0.000291	0.00285	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—liver cancer	0.000288	0.00282	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—liver cancer	0.000285	0.0028	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—liver cancer	0.000284	0.00278	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—liver cancer	0.000284	0.00278	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000282	0.00276	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—liver cancer	0.000281	0.00275	CcSEcCtD
Abiraterone—Oedema—Epirubicin—liver cancer	0.000272	0.00267	CcSEcCtD
Abiraterone—Infection—Epirubicin—liver cancer	0.000271	0.00265	CcSEcCtD
Abiraterone—Cough—Doxorubicin—liver cancer	0.000269	0.00264	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—liver cancer	0.000267	0.00261	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—liver cancer	0.000265	0.00259	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—liver cancer	0.000263	0.00257	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—liver cancer	0.000263	0.00257	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000261	0.00256	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—liver cancer	0.00026	0.00254	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—liver cancer	0.000252	0.00247	CcSEcCtD
Abiraterone—Infection—Doxorubicin—liver cancer	0.00025	0.00245	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000248	0.00243	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—liver cancer	0.000246	0.00241	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—liver cancer	0.000245	0.0024	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—liver cancer	0.000243	0.00238	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—liver cancer	0.00024	0.00235	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000235	0.0023	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—liver cancer	0.000235	0.0023	CcSEcCtD
Abiraterone—Constipation—Epirubicin—liver cancer	0.000233	0.00228	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00023	0.00225	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—liver cancer	0.000228	0.00223	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—liver cancer	0.000225	0.0022	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—liver cancer	0.000222	0.00217	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000218	0.00213	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—liver cancer	0.000217	0.00213	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—liver cancer	0.000216	0.00211	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—liver cancer	0.000215	0.00211	CcSEcCtD
Abiraterone—CYP3A4—liver—liver cancer	0.000215	0.0152	CbGeAlD
Abiraterone—CYP2D6—liver—liver cancer	0.000212	0.015	CbGeAlD
Abiraterone—Body temperature increased—Doxorubicin—liver cancer	0.000199	0.00195	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—liver cancer	0.000195	0.00191	CcSEcCtD
Abiraterone—Diarrhoea—Epirubicin—liver cancer	0.000186	0.00183	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—liver cancer	0.000181	0.00177	CcSEcCtD
Abiraterone—Vomiting—Epirubicin—liver cancer	0.000173	0.0017	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—liver cancer	0.000172	0.00169	CcSEcCtD
Abiraterone—Rash—Epirubicin—liver cancer	0.000172	0.00168	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—liver cancer	0.000172	0.00168	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—liver cancer	0.00016	0.00157	CcSEcCtD
Abiraterone—Rash—Doxorubicin—liver cancer	0.000159	0.00156	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—liver cancer	0.000159	0.00155	CcSEcCtD
Abiraterone—Testosterone—CYP1A1—liver cancer	7.09e-05	0.642	CrCbGaD
Abiraterone—Testosterone—ALB—liver cancer	3.95e-05	0.358	CrCbGaD
Abiraterone—CYP3A4—Biological oxidations—GSTM1—liver cancer	3.61e-05	0.000249	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	3.57e-05	0.000246	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IFNA1—liver cancer	3.56e-05	0.000246	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	3.56e-05	0.000245	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	3.53e-05	0.000243	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GOT2—liver cancer	3.53e-05	0.000243	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.51e-05	0.000242	CbGpPWpGaD
Abiraterone—ALB—Selenium Micronutrient Network—IL6—liver cancer	3.51e-05	0.000242	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—GSTM1—liver cancer	3.49e-05	0.000241	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TAT—liver cancer	3.49e-05	0.00024	CbGpPWpGaD
Abiraterone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.42e-05	0.000236	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HPGDS—liver cancer	3.41e-05	0.000235	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.39e-05	0.000234	CbGpPWpGaD
Abiraterone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.37e-05	0.000233	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—CYP1A1—liver cancer	3.31e-05	0.000228	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	3.19e-05	0.00022	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PRKCE—liver cancer	3.15e-05	0.000217	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.13e-05	0.000216	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	3.11e-05	0.000215	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.11e-05	0.000214	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.08e-05	0.000213	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—MTHFR—liver cancer	3.08e-05	0.000213	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.04e-05	0.00021	CbGpPWpGaD
Abiraterone—ABCC1—Disease—GOT1—liver cancer	3.04e-05	0.00021	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PSMA4—liver cancer	3.04e-05	0.000209	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PSMD10—liver cancer	3.04e-05	0.000209	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PPARA—liver cancer	3.02e-05	0.000209	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	3.01e-05	0.000208	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—ABL1—liver cancer	3e-05	0.000207	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IGF2—liver cancer	2.98e-05	0.000206	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GOT2—liver cancer	2.95e-05	0.000204	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—ALB—liver cancer	2.9e-05	0.0002	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CPT1B—liver cancer	2.89e-05	0.000199	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GLUL—liver cancer	2.89e-05	0.000199	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CPT1B—liver cancer	2.87e-05	0.000198	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GLUL—liver cancer	2.87e-05	0.000198	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	2.86e-05	0.000197	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HGF—liver cancer	2.82e-05	0.000194	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PRKCE—liver cancer	2.81e-05	0.000194	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CSF2—liver cancer	2.79e-05	0.000192	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NR1H4—liver cancer	2.78e-05	0.000192	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP2E1—liver cancer	2.78e-05	0.000191	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NR1H4—liver cancer	2.77e-05	0.000191	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTA3—liver cancer	2.74e-05	0.000189	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTA3—liver cancer	2.72e-05	0.000188	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.72e-05	0.000187	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.69e-05	0.000185	CbGpPWpGaD
Abiraterone—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	2.62e-05	0.000181	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	2.62e-05	0.000181	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYCS—liver cancer	2.6e-05	0.000179	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CG—liver cancer	2.59e-05	0.000179	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UGDH—liver cancer	2.56e-05	0.000176	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GOT1—liver cancer	2.55e-05	0.000176	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GGT1—liver cancer	2.55e-05	0.000176	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTA4—liver cancer	2.5e-05	0.000173	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PPARG—liver cancer	2.5e-05	0.000172	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTA4—liver cancer	2.49e-05	0.000172	CbGpPWpGaD
Abiraterone—ABCC1—Disease—H2AFX—liver cancer	2.45e-05	0.000169	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.45e-05	0.000169	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTA2—liver cancer	2.44e-05	0.000168	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.43e-05	0.000168	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.43e-05	0.000167	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTA2—liver cancer	2.42e-05	0.000167	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—EPT1—liver cancer	2.4e-05	0.000166	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CPT1B—liver cancer	2.37e-05	0.000163	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GLUL—liver cancer	2.37e-05	0.000163	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTA1—liver cancer	2.35e-05	0.000162	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTA1—liver cancer	2.34e-05	0.000161	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NAT2—liver cancer	2.33e-05	0.00016	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NAT2—liver cancer	2.31e-05	0.00016	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTP1—liver cancer	2.29e-05	0.000158	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NR1H4—liver cancer	2.28e-05	0.000158	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—PIK3CA—liver cancer	2.28e-05	0.000157	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TAT—liver cancer	2.28e-05	0.000157	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CD—liver cancer	2.28e-05	0.000157	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HMOX1—liver cancer	2.26e-05	0.000156	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK14—liver cancer	2.26e-05	0.000156	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ALB—liver cancer	2.25e-05	0.000155	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTA3—liver cancer	2.25e-05	0.000155	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.24e-05	0.000154	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALDOB—liver cancer	2.23e-05	0.000154	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.23e-05	0.000154	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.22e-05	0.000153	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTHFR—liver cancer	2.22e-05	0.000153	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALDOB—liver cancer	2.22e-05	0.000153	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TERT—liver cancer	2.21e-05	0.000153	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—F2—liver cancer	2.19e-05	0.000151	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CRABP1—liver cancer	2.13e-05	0.000147	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CRABP1—liver cancer	2.12e-05	0.000146	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.12e-05	0.000146	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTM1—liver cancer	2.1e-05	0.000145	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CG—liver cancer	2.09e-05	0.000144	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTA4—liver cancer	2.05e-05	0.000142	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTA2—liver cancer	2e-05	0.000138	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CYP1A1—liver cancer	1.99e-05	0.000138	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CB—liver cancer	1.98e-05	0.000137	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTA1—liver cancer	1.93e-05	0.000133	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.92e-05	0.000132	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NAT2—liver cancer	1.91e-05	0.000132	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.9e-05	0.000131	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	1.9e-05	0.000131	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APC—liver cancer	1.87e-05	0.000129	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—liver cancer	1.86e-05	0.000128	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HPGDS—liver cancer	1.86e-05	0.000128	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MTHFR—liver cancer	1.86e-05	0.000128	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HPGDS—liver cancer	1.85e-05	0.000128	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.85e-05	0.000128	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CD—liver cancer	1.84e-05	0.000127	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.84e-05	0.000127	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALDOB—liver cancer	1.83e-05	0.000126	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPARA—liver cancer	1.82e-05	0.000126	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SERPINE1—liver cancer	1.82e-05	0.000125	CbGpPWpGaD
Abiraterone—ABCC1—Disease—BRAF—liver cancer	1.75e-05	0.000121	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CRABP1—liver cancer	1.75e-05	0.00012	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.68e-05	0.000116	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.67e-05	0.000115	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.66e-05	0.000115	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PSMD10—liver cancer	1.66e-05	0.000114	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PSMA4—liver cancer	1.66e-05	0.000114	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PSMD10—liver cancer	1.65e-05	0.000114	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PSMA4—liver cancer	1.65e-05	0.000114	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—RAF1—liver cancer	1.64e-05	0.000113	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CD—liver cancer	1.64e-05	0.000113	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.64e-05	0.000113	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SERPINE1—liver cancer	1.62e-05	0.000112	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GOT2—liver cancer	1.61e-05	0.000111	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GOT2—liver cancer	1.6e-05	0.000111	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CB—liver cancer	1.6e-05	0.000111	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CG—liver cancer	1.56e-05	0.000108	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GLUL—liver cancer	1.55e-05	0.000107	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CPT1B—liver cancer	1.55e-05	0.000107	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.55e-05	0.000107	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HPGDS—liver cancer	1.53e-05	0.000105	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP2E1—liver cancer	1.52e-05	0.000105	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPARG—liver cancer	1.51e-05	0.000104	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP2E1—liver cancer	1.51e-05	0.000104	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NR1H4—liver cancer	1.49e-05	0.000103	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—liver cancer	1.47e-05	0.000102	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA3—liver cancer	1.47e-05	0.000101	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.47e-05	0.000101	CbGpPWpGaD
Abiraterone—ABCC1—Disease—RAF1—liver cancer	1.46e-05	0.000101	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.46e-05	0.000101	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CB—liver cancer	1.43e-05	9.86e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTOR—liver cancer	1.43e-05	9.86e-05	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.42e-05	9.8e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYCS—liver cancer	1.42e-05	9.78e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYCS—liver cancer	1.41e-05	9.73e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GGT1—liver cancer	1.39e-05	9.6e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GOT1—liver cancer	1.39e-05	9.6e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GGT1—liver cancer	1.38e-05	9.55e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GOT1—liver cancer	1.38e-05	9.55e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CD—liver cancer	1.37e-05	9.47e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PSMA4—liver cancer	1.36e-05	9.39e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PSMD10—liver cancer	1.36e-05	9.39e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALB—liver cancer	1.36e-05	9.35e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA4—liver cancer	1.34e-05	9.26e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1B—liver cancer	1.34e-05	9.25e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GOT2—liver cancer	1.32e-05	9.13e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA2—liver cancer	1.31e-05	9.03e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CTNNB1—liver cancer	1.27e-05	8.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA1—liver cancer	1.26e-05	8.71e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—liver cancer	1.25e-05	8.63e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTP1—liver cancer	1.25e-05	8.62e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NAT2—liver cancer	1.25e-05	8.61e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP2E1—liver cancer	1.24e-05	8.58e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTP1—liver cancer	1.24e-05	8.57e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1A—liver cancer	1.24e-05	8.54e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMOX1—liver cancer	1.23e-05	8.5e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMOX1—liver cancer	1.23e-05	8.46e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—liver cancer	1.21e-05	8.34e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CB—liver cancer	1.2e-05	8.26e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDOB—liver cancer	1.2e-05	8.26e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYCS—liver cancer	1.16e-05	8.03e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—liver cancer	1.15e-05	7.92e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—liver cancer	1.15e-05	7.92e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GGT1—liver cancer	1.14e-05	7.88e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GOT1—liver cancer	1.14e-05	7.88e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—liver cancer	1.14e-05	7.88e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CRABP1—liver cancer	1.14e-05	7.88e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—liver cancer	1.1e-05	7.62e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A1—liver cancer	1.09e-05	7.51e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A1—liver cancer	1.08e-05	7.47e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KRAS—liver cancer	1.06e-05	7.34e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—liver cancer	1.03e-05	7.08e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTP1—liver cancer	1.03e-05	7.08e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—liver cancer	1.02e-05	7.06e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—liver cancer	1.02e-05	7e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMOX1—liver cancer	1.01e-05	6.98e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—liver cancer	1.01e-05	6.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HPGDS—liver cancer	9.98e-06	6.88e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARA—liver cancer	9.96e-06	6.87e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARA—liver cancer	9.91e-06	6.83e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—liver cancer	9.88e-06	6.82e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—liver cancer	9.77e-06	6.74e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KRAS—liver cancer	9.49e-06	6.54e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—liver cancer	9.46e-06	6.52e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—liver cancer	9.43e-06	6.51e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—HRAS—liver cancer	9.04e-06	6.24e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.95e-06	6.17e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A1—liver cancer	8.94e-06	6.17e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.9e-06	6.14e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PSMA4—liver cancer	8.9e-06	6.14e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PSMD10—liver cancer	8.9e-06	6.14e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—liver cancer	8.72e-06	6.01e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GOT2—liver cancer	8.66e-06	5.97e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CG—liver cancer	8.53e-06	5.88e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CG—liver cancer	8.48e-06	5.85e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—liver cancer	8.34e-06	5.75e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARG—liver cancer	8.24e-06	5.68e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARG—liver cancer	8.19e-06	5.65e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARA—liver cancer	8.18e-06	5.64e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2E1—liver cancer	8.14e-06	5.61e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—HRAS—liver cancer	8.06e-06	5.56e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—liver cancer	7.98e-06	5.51e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—liver cancer	7.72e-06	5.32e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYCS—liver cancer	7.61e-06	5.25e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CD—liver cancer	7.5e-06	5.17e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GGT1—liver cancer	7.47e-06	5.15e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GOT1—liver cancer	7.47e-06	5.15e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CD—liver cancer	7.46e-06	5.14e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALB—liver cancer	7.4e-06	5.11e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—liver cancer	7.3e-06	5.03e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—liver cancer	7.12e-06	4.91e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CG—liver cancer	7e-06	4.83e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARG—liver cancer	6.76e-06	4.66e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTP1—liver cancer	6.71e-06	4.63e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMOX1—liver cancer	6.62e-06	4.56e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CB—liver cancer	6.54e-06	4.51e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CB—liver cancer	6.5e-06	4.48e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—liver cancer	6.17e-06	4.25e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CD—liver cancer	6.16e-06	4.25e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALB—liver cancer	6.08e-06	4.19e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—liver cancer	5.96e-06	4.11e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A1—liver cancer	5.85e-06	4.03e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—liver cancer	5.45e-06	3.76e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CB—liver cancer	5.37e-06	3.7e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARA—liver cancer	5.35e-06	3.69e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CG—liver cancer	4.58e-06	3.16e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARG—liver cancer	4.42e-06	3.05e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CD—liver cancer	4.03e-06	2.78e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—liver cancer	3.99e-06	2.75e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALB—liver cancer	3.97e-06	2.74e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—liver cancer	3.96e-06	2.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CB—liver cancer	3.51e-06	2.42e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—liver cancer	3.27e-06	2.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—liver cancer	3.26e-06	2.25e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—liver cancer	3.24e-06	2.23e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—liver cancer	2.67e-06	1.84e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—liver cancer	2.14e-06	1.48e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—liver cancer	1.75e-06	1.21e-05	CbGpPWpGaD
